Karen Mossman has been chosen to receive the 2024 ICIS Honorary Lifetime Membership Award
Awards

Karen Mossman has been chosen to receive the 2024 ICIS Honorary Lifetime Membership Award

Professor Karen Mossman has been selected as the recipient of the 2024 ICIS Honorary Lifetime Membership Award in recognition for her scientific accomplishments that center around basic virology, interferon responses and how to exploit this fundamental knowledge for clinical benefit as well as her long time commitment to the scientific community and members of the ICIS. [READ MORE]

img-3
Members in the News

ICIS Member, Dr. John O’Shea, Scientific Director of Intramural Research, Elected to the U.S. National Academy of Sciences

On May 2, 2023, NIAMS Scientific Director of Intramural Research, Dr. John O’Shea, was elected to the U.S. National Academy of Sciences at the conclusion of the Academy’s 160th annual meeting. This designation – considered one of the highest honors that a scientist can achieve – recognizes distinguished and continuing achievements in original research.  [READ MORE]

Christopher Garcia is the 2024 Passano Award winner
Members in the News
We've Moved
Society News

We’ve Moved!

The ICIS continues to be managed as a virtual office, now with one office in San Francisco and one in Germany. Since the society is a US registered non-profit organization that has been incorporated in the US, and Co-Managing Director, Stephanie Flores is located in San Francisco, please use the [READ MORE]

2024 Mentorship Award: Susan Kaech is a Salk Institute Professor, Director of the NOMIS Center for Immunobiology and Microbial Pathogenesis, and holder of the NOMIS Chair
Awards

Susan Kaech is the 2024 ICIS Mentorship Award Winner

Susan Kaech is the 2024 ICIS Mentorship Award Winner in recognition not only of her cutting-edge research and seminal discoveries and scientific accomplishment, but for her ardent sponsorship and relentless championship of the junior faculty she has helped in the establishment and success of their own independent research programs. She is known as a “forever-mentor” who cares more about her trainees (and often those completely unrelated to her lab) than she does about her own career, strongly supporting people in her lab long after they have left the lab. [READ MORE]

ICIS Member and 2019 Milstein Award Winner, Professor Akiko Iwasaki, renowned immunologist, has been named to both the TIME100 and TIME100 Health, two of Time Magazine's lists of the most influential people of 2024. The honor recognizes her pioneering research into post-acute infection syndromes like LlongCOVID.
Members in the News

ICIS Member Akiko Iwasaki has been named to both the TIME100 and TIME100 Health Lists of Most Influential People & in Health in 2024

ICIS Member and 2019 Milstein Award Winner, Professor Akiko Iwasaki, renowned immunologist, has been named to both the TIME100 and TIME100 Health, two of Time Magazine’s lists of the most influential people of 2024. The honor recognizes her pioneering research into post-acute infection syndromes like LongCOVID. [READ MORE]

Georg Schett Courtesy Uniklinikum Erlangen/Simone Kessler—SIMOarts
Members in the News

Georg Schett’s Autoimmunity breakthrough recognized by inclusion in the Time100 Health List of 100 Most Influential People in Health in 2024

Dr. Georg Schett, a world renown rheumatologist at the University Hospital Erlangen in Germany who chaired Cytokines 20219 in Vienna, has been named to Time Magazine’s 100 Most Influential People in Health for 2024 for his work using CAR T therapy to treat Autoimmune Diseases. Dr. Schett saw the potential of new immune-based therapy CAR T which dramatically improved outcomes for patients with certain blood cancers that involve B cells, like leukemia and lymphoma, as a promising treatment for autoimmune diseases like lupus, in which immune B cells attack the body’s own cells. He performed the first CAR T treatments on five patients with the disease in 2022. Eight months after receiving the therapy, all five were in remission and no longer needed powerful immunosuppressive drugs to control their disease. Last year, Schett published a second groundbreaking study showing that another small group of patients receiving the therapy were still in remission more than two years later without immunosuppressive drugs. [READ MORE]

Distinguished Lecturer Christopher A. Hunter’s lecture, From parasites to mRNA vaccines: cytokine networks that dictate T cell tempo
Members in the News